
Coughing is a reflex predominantly mediated by control centers in respiratory areas of the brainstem, which is modulated by the cerebral cortex.

Aislinn Antrim is managing editor at Pharmacy Times®. She graduated from the University of North Carolina at Chapel Hill in 2019 and received her master’s in communication and media at Rutgers University in 2023.

Coughing is a reflex predominantly mediated by control centers in respiratory areas of the brainstem, which is modulated by the cerebral cortex.

Results suggest pharmacists should use the phrase “bad reaction” to avoid stigma associated with the term “overdose.”

Three key opportunities for oncology stewardship are dose rounding, implementation of biosimilars, and management of sites of care.

Implementing screening tools, conducting brief interventions, and involving pharmacists can help manage alcohol use disorder and Alcohol Withdrawal Syndrome.

The findings could also help explain why certain comorbidities persist following other viral infections, including COVID-19.

The 2022 theme is “Putting Ourselves to the Test: Achieving Equity to End HIV.”

Pharmacy Times will be covering the American Society of Health-System Pharmacists 2022 Midyear Clinical Meeting from December 4 to 8.

Instagram offers a myriad of ways to share content and connect with others.

Educating patients while remaining empathetic, sharing personal experiences helps overcome this hurdle.

Researchers also noted an increasing rate of seroconversion with COVID-19 booster vaccination series.

Findings support the potential protective association of vaccination in reducing long COVID, although it does not appear to eliminate the risk.

Despite an apparent benefit of intravenous immunoglobulin (IVIG) on early discharge, the likelihood of needing second-line treatment was 3 times higher in patients who initiated treatment with IVIG alone.

Study suggests states maintaining higher health care expenditures are more attentive to price transparency initiatives and tend to adopt all-payer claims databases.

Zilucoplan is a subcutaneous, self-administered peptide inhibitor of complement component 5.

Intravenous immunoglobulin is used for several autoimmune and inflammatory conditions, although researchers have not fully understood its specific mechanisms.

Efficacy results comparing the cemiplimab-rwlc combination to chemotherapy alone showed a 22-month median overall survival versus 13 months.

Tetracyclines have been shown to offer some degree of immune protection resulting in mucosal healing, and in this study, they had one of the smaller associations with herpes zoster.

However, findings do not preclude the possibility that mechanisms other than cardiac remodeling may be responsible for benefits of SGLT2 inhibition.

Approximately 10% of patients in trial experienced a heart attack, stroke, blocked arteries requiring treatment, or death from cardiovascular disease.

Intravenous iron reduced the risk of hospitalization for heart failure or cardiovascular death by approximately 20%.

Chlorthalidone was associated with more individuals with potassium levels below 3.1 mmol/L, suggesting a greater risk of hypokalemia.

Experts said the results will likely not alter practice and clinicians will likely continue to use torsemide.

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

FDA Commissioner Robert Califf said that misinformation is the most common cause of death in the United States.

WHO has released a global plan for hepatitis B elimination by 2030, including goals to increase pediatric and maternal immunization and to improve screening and treatment.

Psoriasis and end-stage renal disease are believed to share multiple pathogenic pathways, including various cytokines, reactive oxygen species, and psoriasis medications.

Eisai plans to file for traditional approval in the United States by March 31, 2023.

Problems such as sleep deprivation, excessive sleeping, or inability to sleep regularly may be an important factor in the transition from episodic to chronic migraines.

IMU-935 is a highly potent and selective inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma/truncated.

Although clinicians cited lack of time as a reason for not using patient-reported outcomes, patients with HIV viewed their use very positively.